Form 4 for HAE HAEMONETICS CORP
Accepted 2023-01-25 00:00:00 ET · period of report 2023-01-23 · accession 0001127602-23-002187 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-25 | 2023-01-23 | HAE | Llorens Josep | EVP, Gbl Manufacturing | M - OptEx | $56.57 | +2,391 | 19.6K | +14% | +$135.3K |
| D | 2023-01-25 | 2023-01-23 | HAE | Llorens Josep | EVP, Gbl Manufacturing | S - Sale+OE | $90.00 | -2,391 | 17.2K | -12% | -$215.2K |
| D | 2023-01-25 | 2023-01-23 | HAE | Llorens Josep | EVP, Gbl Manufacturing | M - OptEx | $0.00 | -2,391 | 7,173 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-23 | M | A | 2,391 | $56.57 | 19,625 | D | — | — | (F2) This number includes unvested restricted stock units previously reported. |
| 2 | Common | Common Stock | 2023-01-23 | S | D | 2,391 | $90.00 | 17,234 | D | — | — | (F2) This number includes unvested restricted stock units previously reported. |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-01-23 | M | D | 2,391 | $0.00 | 7,173 | D | $56.57 · 2022-05-18 to 2028-05-18 | 2,391 Common Stock | (F3) Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |